SUS CLINICALS Trademark

Trademark Overview


On Friday, August 13, 2021, a trademark application was filed for SUS CLINICALS with the United States Patent and Trademark Office. The USPTO has given the SUS CLINICALS trademark a serial number of 90881874. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by Sus Clinicals, Inc.. The SUS CLINICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical and laboratory research and testing, research testing of materials, namely, the use of genetically-engineered pigs, into which an adenoviral vector encoding Cre recombinase is induced, resulting in the formation of tumors in the target organ; research testing protocols conducting testing on tumors via drug or medical device, with subsequent collection of data, tissue samples, and/or images to assess the development and performance of cancer treatments, diagnostics, devices, and drugs
sus clinicals

General Information


Serial Number90881874
Word MarkSUS CLINICALS
Filing DateFriday, August 13, 2021
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7009210
Registration DateTuesday, March 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Translation of Words in MarkThe English translation of "SUS" in the mark is "their" or "your".
Disclaimer with Predetermined Text"CLINICALS"
Goods and ServicesClinical and laboratory research and testing, research testing of materials, namely, the use of genetically-engineered pigs, into which an adenoviral vector encoding Cre recombinase is induced, resulting in the formation of tumors in the target organ; research testing protocols conducting testing on tumors via drug or medical device, with subsequent collection of data, tissue samples, and/or images to assess the development and performance of cancer treatments, diagnostics, devices, and drugs

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 18, 2022
Primary Code042
First Use Anywhere DateFriday, July 17, 2020
First Use In Commerce DateFriday, July 17, 2020

Trademark Owner History


Party NameSus Clinicals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45243

Party NameSus Clinicals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45243

Party NameSus Clinicals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45243

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 2, 2022EXAMINER'S AMENDMENT ENTERED
Friday, December 2, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 2, 2022EXAMINERS AMENDMENT E-MAILED
Friday, December 2, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, November 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 21, 2022NON-FINAL ACTION E-MAILED
Saturday, May 21, 2022NON-FINAL ACTION WRITTEN
Sunday, May 15, 2022ASSIGNED TO EXAMINER
Monday, October 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 17, 2021NEW APPLICATION ENTERED